-
EMA warns consumers about falsified COVID-19 drugs from online pharmacies
europeanpharmaceuticalreview
April 01, 2020
The European Medicines Agency (EMA) has advised consumers on how to recognise registered online pharmacies so they can avoid falsified medications.
-
US urges India to lift export ban on pharmaceutical ingredients
pharmaceutical-technology
April 01, 2020
Officials of the US have asked India to lift the ban imposed on export of pharmaceutical ingredients amid the Covid-19 coronavirus pandemic.
-
US HHS expedites development and manufacture of Covid-19 vaccines
pharmaceutical-technology
April 01, 2020
The US Department of Health and Human Services (HHS) is accelerating the development and manufacture of vaccines against the Covid-19 coronavirus infection.
-
Noveome studies anti-inflammatory drug ST266 in Covid-19
pharmaceutical-technology
April 01, 2020
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential treatment of severe cytokine storm response associated with Covid-19.
-
GigaGen works on recombinant polyclonal antibody against Covid-19
pharmaceutical-technology
April 01, 2020
Biotechnology company GigaGen is working on a recombinant polyclonal antibody, recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG), as a Covid-19 treatment.
-
Aptorum and Covar explore repurposed drugs for coronavirus
pharmaceutical-technology
April 01, 2020
Aptorum Group is set to choose at least three repurposed drug candidates for Covid-19 treatment, out of nearly 2,600 approved small drug molecules screened using its Smart-ACT drug discovery platform.
-
Cobra Biologics Joins COVID-19 Consortium
contractpharma
April 01, 2020
Aims to rapidly develop, scale-up and produce potential adenoviral vaccine candidate for COVID-19.
-
Coronavirus Consortium Accelerates Immunotherapy Research
contractpharma
April 01, 2020
To leverage Carterra’s LSA platform to screen hundreds of antibodies in a few days as CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks.
-
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19
expresspharma
April 01, 2020
The company will also establish a new US Vaccine manufacturing capabilities and additional production capacity outside the US to begin production at risk to help ensure global vaccine supply.
-
Laurus Labs and Rising Pharma to collaborate on a clinical trial for preventive COVID-19 treatment
expresspharma
April 01, 2020
They will work with University of Minnesota to explore hydroxychloroquine as preventive treatment for coronavirus disease 2019.